Introduction: Personalized Medicine in Gastrointestinal Cancer

被引：1
作者：
Riall, Taylor S. [1 ]
机构：
[1] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA
来源：
JOURNAL OF GASTROINTESTINAL SURGERY | 2012年 / 16卷 / 09期
关键词：
Personalized medicine; Translational research; Genomics; Proteomics; GASTRIC-CANCER; OVARIAN-CANCER; BREAST; CETUXIMAB; PROMISES; CARRIERS; SURGERY;
D O I：
10.1007/s11605-012-1948-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1639 / 1640
页数：2
相关论文
共 15 条
  • [1] Preventing breast, ovarian cancer in BRCA carriers: Rational of prophylactic surgery and promises of surveillance
    Agnantis, NJ
    Paraskevaidis, E
    Roukos, D
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (12) : 1030 - 1034
  • [2] Familial gastric cancer - aetiology and pathogenesis
    Barber, Miriam
    Fitzgerald, Rebecca C.
    Caldas, Carlos
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (04) : 721 - 734
  • [3] KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
    De Roock, W.
    Piessevaux, H.
    De Schutter, J.
    Janssens, M.
    De Hertogh, G.
    Personeni, N.
    Biesmans, B.
    Van Laethem, J. -L.
    Peeters, M.
    Humblet, Y.
    Van Cutsem, E.
    Tejpar, S.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (03) : 508 - 515
  • [4] Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
    Di Fiore, F.
    Blanchard, F.
    Charbonnier, F.
    Le Pessot, F.
    Lamy, A.
    Galais, M. P.
    Bastit, L.
    Killian, A.
    Sesboue, R.
    Tuech, J. J.
    Queuniet, A. M.
    Paillot, B.
    Sabourin, J. C.
    Michot, F.
    Michel, P.
    Frebourg, T.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1166 - 1169
  • [5] Hutchins G, 2011, J CONTRACEPT FERTIL
  • [6] DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
    Iacobuzio-Donahue, Christine A.
    Fu, Baojin
    Yachida, Shinichi
    Luo, Mingde
    Abe, Hisashi
    Henderson, Clark M.
    Vilardell, Felip
    Wang, Zheng
    Keller, Jesse W.
    Banerjee, Priya
    Herman, Joseph M.
    Cameron, John L.
    Yeo, Charles J.
    Halushka, Marc K.
    Eshleman, James R.
    Raben, Marian
    Klein, Alison P.
    Hruban, Ralph H.
    Hidalgo, Manuel
    Laheru, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1806 - 1813
  • [7] More controversy than ever - Challenges and promises towards personalized treatment of gastric cancer
    Liakakos, Theodore
    Roukos, Dimitrios H.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) : 956 - 960
  • [8] Personalized cancer therapy for gastrointestinal stromal tumor: synergizing tumor genotyping with imatinib plasma levels
    Marrari, Andrea
    Trent, Jonathan C.
    George, Suzanne
    [J]. CURRENT OPINION IN ONCOLOGY, 2010, 22 (04) : 336 - 341
  • [9] The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program
    Mukherjee, Aparna
    McGarrity, Thomas J.
    Ruggiero, Francesca
    Koltun, Walter
    McKenna, Kevin
    Poritz, Lisa
    Baker, Maria J.
    [J]. HEREDITARY CANCER IN CLINICAL PRACTICE, 2010, 8
  • [10] Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations
    Roukos, DH
    Agnanti, NJ
    Paraskevaidis, E
    Kappas, AM
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) : 941 - 943
12